Automated time-resolved immunofluorometric assay for progastrin-releasing peptide

Clinical Chemistry

Volumn 54, Issue 5, 2008, Pages 919-922

  Nordlund, Marianne S ^a   Warren, David J ^a   Nustad, Kjell ^a   Bjerner, Johan ^a   Paus, Elisabeth ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MONOCLONAL ANTIBODY; PROGASTRIN RELEASING PEPTIDE;

ANIMAL CELL; ARTICLE; AUTOMATION; BINDING AFFINITY; CONTROLLED STUDY; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; HUMAN; HUMAN CELL; IMMUNIZATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; SOLID STATE;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANALYSIS; CARCINOMA, SMALL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROIMMUNOASSAY; GASTRIN-RELEASING PEPTIDE; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; PHOSPHOPYRUVATE HYDRATASE; PROTEIN PRECURSORS; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 43449084950     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.101436     Document Type: Article

References (17)

1. Takada M, Kusunoki Y, Masuda N, Matui K, Yana T, Ushijima S, et al. Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase. Br J Cancer 1996;73:1227-32.
2. Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, Yamaguchi K. Progastrin-releasing peptide (ProGRP): a useful marker in small cell lung carcinomas. Anticancer Res 1999;19:2673-8.
3. Miyake Y, Kodama T, Yamaguchi K. Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1994;54:2136-40.
4. Dumesny C, Patel O, Lachal S, Giraud AS, Baldwin GS, Shulkes A. Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP). Endocrinology 2006;147:502-9.
5. Aoyagi K, Miyake Y, Urakami K, Kashiwakuma T, Hasegawa A, Kodama T, Yamaguchi K. Enzyme immunoassay of immunoreactive progastrin-releasing peptide(31-98) as tumor marker for small-cell lung carcinoma: development and evaluation. Clin Chem 1995;41:537-43.
6. Nordlund MS, Fermer C, Nilsson O, Warren DJ, Paus E. Production and characterization of monoclonal antibodies for immunoassay of the lung cancer marker proGRP. Tumour Biol 2007;28:100-10.
7. Grant G.A. Synthetic peptides for production of antibodies that recognize intact proteins. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current protocols in immunology. New York: John Wiley & Sons; 2003. p 9.2.1-19.
8. Aasheim HC, Munthe E, Funderud S, Smeland EB, Beiske K, Logtenberg T. A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood 2000;95:221-30.
9. Nustad K, Dowell BL, Davis GJ, Stewart K, Nilsson O, Roijer E et al. Characterization of monoclonal antibodies directed against squamous cell carcinoma antigens: report of the TD-10 Workshop. Tumour Biol 2004;25:69-90.
10. Galfre G, Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 1981;73:3-46.
11. Warren DJ, Bjerner J, Paus E, Bormer OP, Nustad K. Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies. Clin Chem 2005;51:830-8.
12. Paus E, Nustad K, Bormer OP. Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen. Tumour Biol 1999;20(Suppl 1):52- 69.
13. Paus E, Nustad K. Immunoradiometric assay for alpha gamma- and gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles. Clin Chem 1989;35:2034-8.
14. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995;346:1085-7.
15. Kristensen P, Winter G. Proteolytic selection for protein folding using filamentous bacteriophages. Fold Des 1998;3:321-8.
16. Bjerner J, Nustad K, Norum LF, Olsen KH, Bormer OP. Immunometric assay interference: incidence and prevention. Clin Chem 2002;48:613-21.
17. Yoshimura T., Fujita K., Kawakami S., Kitahara M., Dowell B. Stability of pro-gastrin releasing peptide in serum and plasma [Abstract]. Tumor Biol 2007;28(Suppl 1):109.